Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cell Transplantation|April 24, 2020
Comparative Efficacy and Clinical Outcomes of Haploidentical Stem Cell Transplantation to Other Stem Sources for Treatment in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients: A Systematic Review and Meta-AnalysisChutima Kunacheewa, Patompong Ungprasert, Ployploen Phikulsod, et al.Technology in Cancer Research & Treatment|June 30, 2022
Comparison of Clinical Characteristics and Genetic Aberrations of Plasma Cell Disorders in Thailand PopulationChutirat Jirabanditsakul, Sumana Dakeng, Chutima Kunacheewa, et al.Pathology Oncology Research : POR|February 10, 2023
High prevalence of Wilms tumor 1 expression in multiple myeloma and plasmacytoma: A cohort of 142 Asian patients' samplesPloyploen Phikulsod, Sanya Sukpanichnant, Chutima Kunacheewa, et al.Scientific Reports|July 5, 2025
Advancing the pathway to allogeneic hematopoietic stem cell transplantation through a physician-nurse coordinator system in patients with acute leukemiaChidapa Auepisit, Weerapat Owattanapanich, Smith Kungwankiattichai, et al.Transplantation and Cellular Therapy|October 20, 2025
Optimizing Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Early Step-Down Ward Versus HEPA-Filtered Rooms: A Practical Approach for Resource-Limited SettingsChutima Kunacheewa, Sukanpuk Niwatkittipon, Suparat Atakulreka, et al.Molecular Therapy. Oncology|November 7, 2024
Point-of-care manufacturing of anti-CD19 CAR-T cells using a closed production platform: Experiences of an academic in ThailandSudjit Luanpitpong, Phatchanat Klaihmon, Montira Janan, et al.Clinical Lymphoma, Myeloma & Leukemia|February 11, 2020
Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective StudyChutima Kunacheewa, Hans C Lee, Krina Patel, et al.Journal of Blood Medicine|April 4, 2025
Optimizing Haploidentical Hematopoietic Stem Cell Transplantation: Enhancing Outcomes in Hematologic Malignancies in Resource-Limited SettingsWeerapat Owattanapanich, Ekapun Karoopongse, Janejira Kittivorapart, et al.Clinical Lymphoma, Myeloma & Leukemia|June 16, 2019
Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell LeukemiaSamer Tabchi, Rajit Nair, Chutima Kunacheewa, et al.The Lancet Regional Health. Western Pacific|June 19, 2025
Imaging in plasma cell disorders-consensus recommendations of the Asian myeloma network bone imaging workgroupChandramouli Nagarajan, Natasha Fay Anthony, Jens Hillengass, et al.Pageof 2